ICH Q9(R1) Quality Risk Management Revision – Public Consultation

被引：0
|
作者：
Pluta, Paul L.
机构：
来源：
Journal of Validation Technology | 2021年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 39 条
  • [21] Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines
    Bohdana Ratitch
    Niti Goel
    Craig Mallinckrodt
    James Bell
    Jonathan W. Bartlett
    Geert Molenberghs
    Pritibha Singh
    Ilya Lipkovich
    Michael O’Kelly
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 370 - 384
  • [22] Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines
    Ratitch, Bohdana
    Goel, Niti
    Mallinckrodt, Craig
    Bell, James
    Bartlett, Jonathan W.
    Molenberghs, Geert
    Singh, Pritibha
    Lipkovich, Ilya
    O'Kelly, Michael
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 370 - 384
  • [23] 从审评角度谈适用ICH E9(R1)的初步考虑
    李新旭
    周军
    唐智敏
    卢明亮
    谭明敏
    王景朝
    中国食品药品监管 , 2022, (05) : 40 - 47
  • [24] Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic
    Yongming Qu
    Ilya Lipkovich
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 984 - 988
  • [25] The ICH E9(R1) Estimand Framework in the Context of Real-World Data and Observational Studies
    Husemoen, Lotte
    Morga, Antonia
    Remiro-Azocar, Antonio
    Kleinjung, Frank
    Rantell, Khadija Rerhou
    Besseghir, Amel
    Rosettani, Barbara
    Allignol, Arthur
    Vaitsiakhovich, Tatsiana
    Polavieja, Pepa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 553 - 554
  • [26] Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic
    Qu, Yongming
    Lipkovich, Ilya
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (05) : 984 - 988
  • [27] (Q)SAR Assessment of Potentially Mutagenic Impurities in Pharmaceuticals and Medical Devices according to ICH M7(R1)
    Joel, M.
    Bertels, L. K.
    Foell, R.
    Lewin, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 84 - 84
  • [28] Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1)
    Nicotra, Tess
    Desnos, Aurelie
    Halimi, Justine
    Antonot, Helene
    Reppel, Loic
    Belmas, Thomas
    Freton, Alice
    Stranieri, Floriane
    Mebarki, Miryam
    Larghero, Jerome
    Cras, Audrey
    Faivre, Lionel
    STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [29] Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1)
    Tess Nicotra
    Aurélie Desnos
    Justine Halimi
    Hélène Antonot
    Loïc Reppel
    Thomas Belmas
    Alice Freton
    Floriane Stranieri
    Miryam Mebarki
    Jérôme Larghero
    Audrey Cras
    Lionel Faivre
    Stem Cell Research & Therapy, 11
  • [30] ICH E9(R1)对临床试验统计学的新要求
    阎小妍
    姚晨
    中国新药杂志, 2018, 27 (11) : 1262 - 1265
1234